Docoh
Loading...

AMYT Amryt Pharma

101 filings

Page 4 of 6
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
SC 13G
AMYT Amryt Pharma Plc
5 Feb 21
Amryt Pharma / HIGHBRIDGE CAPITAL MANAGEMENT ownership change
8:18am
6-K
AMYT Amryt Pharma Plc
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
EFFECT
AMYT Amryt Pharma Plc
15 Jan 21
Notice of effectiveness
12:15am
424B4
AMYT Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
AMYT Amryt Pharma Plc
11 Jan 21
Registration statement (foreign) (amended)
7:00pm
CORRESP
AMYT Amryt Pharma Plc
10 Jan 21
Correspondence with SEC
7:00pm
F-1
AMYT Amryt Pharma Plc
8 Jan 21
Registration statement (foreign)
4:58pm
CORRESP
AMYT Amryt Pharma Plc
7 Jan 21
Correspondence with SEC
7:00pm
UPLOAD
AMYT Amryt Pharma Plc
22 Dec 20
Letter from SEC
7:00pm
SC 13G
AMYT Amryt Pharma Plc
22 Dec 20
Amryt Pharma / STONEPINE CAPITAL ownership change
4:21pm
DRS
AMYT Amryt Pharma Plc
17 Dec 20
Draft registration statement
7:00pm
6-K
AMYT Amryt Pharma Plc
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
AMYT Amryt Pharma Plc
9 Dec 20
Current report (foreign)
4:23pm
6-K
AMYT Amryt Pharma Plc
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
AMYT Amryt Pharma Plc
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
AMYT Amryt Pharma Plc
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
AMYT Amryt Pharma Plc
3 Nov 20
Current report (foreign)
8:45am
6-K
AMYT Amryt Pharma Plc
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
AMYT Amryt Pharma Plc
19 Oct 20
Current report (foreign)
8:00am
6-K
AMYT Amryt Pharma Plc
15 Sep 20
Current report (foreign)
8:31am